Advertisement

Topics

FDA approves bevacizumab plus chemotherapy for women with advanced ovarian cancer following initial surgery

06:02 EDT 14 Jun 2018 | ecancermedicalscience

The U.S. Food and Drug Administration (FDA) has approved bevacizumab in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following...

Original Article: FDA approves bevacizumab plus chemotherapy for women with advanced ovarian cancer following initial surgery

NEXT ARTICLE

More From BioPortfolio on "FDA approves bevacizumab plus chemotherapy for women with advanced ovarian cancer following initial surgery"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...